Who are Bedrock Therapeutics, Inc.'s investors?

Bedrock Therapeutics, Inc.'s investors include Department of Health and Human Services.

When was Bedrock Therapeutics, Inc. founded?

Bedrock Therapeutics, Inc. was founded in 2020.

Where is Bedrock Therapeutics, Inc. headquartered?

Bedrock Therapeutics, Inc. is headquartered in Raleigh, North Carolina, United States.

What industry is Bedrock Therapeutics, Inc. in?

Bedrock Therapeutics, Inc. operates in Biotech, Healthcare.

How many employees does Bedrock Therapeutics, Inc. have?

Bedrock Therapeutics, Inc. has 1-10 employees.

Bedrock Therapeutics, Inc.

AAV Gene Therapy R&D

Raleigh, United States · Founded 2020

Biotech

Healthcare

Headquarters: Raleigh, North Carolina
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: bedrocktherapeutics.com
Last Round: GrantJan 2025
Rounds: 2

About

Bedrock Therapeutics is an AAV gene therapy research and development company developing platform technologies and therapeutics. The company focuses on using adeno-associated virus (AAV) vectors to develop treatments for genetic diseases, with projects including improving success rates of human corneal transplants by modulating the immune response. Bedrock Therapeutics is a spinout with ties to UNC/NC State and is based in Raleigh, North Carolina.

Summary

Bedrock Therapeutics, Inc. is a Biotech company based in Raleigh, United States, founded in 2020. Its most recent funding was a Grant round in Jan 2025. Investors include Department of Health and Human Services.